Sesn2 deficiency exaggerated hyper-nutrition and obesity-associated insulin resistance and hepato-steatosis through chronic activation of mTORC1-p70/S6K signaling, which could be effectively reversed by metformin treatment via activating AMPKα (Lee et al., 2012). Here, SESN2 is linked to obesity disorder.